Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
75 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
Condition: Encephalitis
Interventions: Biological: 0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)
2 Not yet recruiting A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China
Condition: Influenza
Intervention: Biological: inactivated quadrivalent influenza vaccine (split virion)
3 Not yet recruiting Hepatitis B Vaccination in Infants
Conditions: Meningococcal Disease;   Pneumococcal Disease;   Haemophilus Influenzae Serotype b Disease;   Diphtheria, Tetanus and Pertussis;   Hepatitis b
Interventions: Biological: Menjugate;   Biological: Menitorix;   Biological: NeisVac-C
4 Not yet recruiting The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
Conditions: Rabies;   Healthy
Interventions: Biological: 2.5IU/ml in rabies vaccine (MRC-5 Cell) humans aged 10-20 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans aged 21-60 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 10-20 years old);   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 21-60 years old)
5 Not yet recruiting Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
Condition: Influenza
Intervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
6 Recruiting Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
7 Recruiting A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland
Condition: Ebola Vaccines
Intervention: Biological: cAd3-EBOZ
8 Recruiting Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children
Condition: Immune Response to MMR Vaccine
Intervention: Biological: MMR vaccine
9 Recruiting Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Condition: Meningitis
Interventions: Biological: Minhai Bio;   Biological: Hualan Bio
10 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
11 Unknown  Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Conditions: High Risk HLA-A2+ Melanoma;   Metastatic Disease
Intervention: Biological: Melanoma vaccine modified to express HLA A2/4-1BB ligand
12 Recruiting The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
13 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
14 Unknown  Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine
Condition: Influenza
Intervention: Biological: 2012 trivalent influenza vaccine
15 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001;   Other: Laboratory Biomarker Analysis
16 Recruiting Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip
17 Recruiting Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Conditions: Immunogenicity;   Reactogenicity
Intervention: Biological: Trivivac vaccine
18 Not yet recruiting Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Condition: Tuberculosis
Intervention: Biological: Ad5Ag85A
19 Unknown  Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
Condition: Influenza
Intervention: Drug: AdimFlu-S
20 Recruiting Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Myelodysplastic Syndrome;   Multiple Myeloma;   Aplastic Anemia
Intervention: Biological: allogeneic donor derived B-lymphocytes

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years